{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T12:39:49Z","timestamp":1780922389299,"version":"3.54.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,21]]},"DOI":"10.7759\/cureus.95037","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T09:47:21Z","timestamp":1761040041000},"source":"Crossref","is-referenced-by-count":1,"title":["A Case of Primary Central Nervous System Lymphoma Mimicking a Demyelinating Disorder: From Steroids to Stem Cell Transplant"],"prefix":"10.7759","author":[{"given":"Sumana Reddy","family":"Tanigundala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishesh Anil","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravikrishna","family":"Madala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Primary central nervous system lymphoma: epidemiology and clinical presentation","volume":"5","author":"Song KW","year":"2021","unstructured":"Song KW, Issa S, Batchelor TT. Primary central nervous system lymphoma: epidemiology and clinical presentation. Ann Lymphoma. 2021, 5:7225.","journal-title":"Ann Lymphoma"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.2000.92.2.0261","article-title":"Primary intracerebral malignant lymphoma: report of 248 cases","volume":"92","author":"Bataille B","year":"2000","unstructured":"Bataille B, Delwail V, Menet E, et al.. Primary intracerebral malignant lymphoma: report of 248 cases. J Neurosurg. 2000, 92:261-6. 10.3171\/jns.2000.92.2.0261","journal-title":"J Neurosurg"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/1470-7330-14-22","article-title":"MR imaging features of intracranial primary CNS lymphoma in immune competent patients","volume":"14","author":"Mansour A","year":"2014","unstructured":"Mansour A, Qandeel M, Abdel-Razeq H, Abu Ali HA. MR imaging features of intracranial primary CNS lymphoma in immune competent patients. Cancer Imaging. 2014, 14:22. 10.1186\/1470-7330-14-22","journal-title":"Cancer Imaging"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A2171","article-title":"Central nervous system lymphoma: characteristic findings on traditional and advanced imaging","volume":"32","author":"Haldorsen IS","year":"2011","unstructured":"Haldorsen IS, Espeland A, Larsson EM. Central nervous system lymphoma: characteristic findings on traditional and advanced imaging. AJNR Am J Neuroradiol. 2011, 32:984-92. 10.3174\/ajnr.A2171","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A1447","article-title":"CT and MR imaging features of primary central nervous system lymphoma in Norway, 1989-2003","volume":"30","author":"Haldorsen IS","year":"2009","unstructured":"Haldorsen IS, Kr\u00e5kenes J, Krossnes BK, Mella O, Espeland A. CT and MR imaging features of primary central nervous system lymphoma in Norway, 1989-2003. AJNR Am J Neuroradiol. 2009, 30:744-51. 10.3174\/ajnr.A1447","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/3606970","article-title":"Primary CNS lymphomas: challenges in diagnosis and monitoring","volume":"2018","author":"Chiavazza C","year":"2018","unstructured":"Chiavazza C, Pellerino A, Ferrio F, Cistaro A, Soffietti R, Rud\u00e0 R. Primary CNS lymphomas: challenges in diagnosis and monitoring. Biomed Res Int. 2018, 2018:3606970. 10.1155\/2018\/3606970","journal-title":"Biomed Res Int"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_200829","article-title":"Treatment of primary central nervous system lymphoma: from chemotherapy to small molecules","volume":"38","author":"Mendez JS","year":"2018","unstructured":"Mendez JS, Grommes C. Treatment of primary central nervous system lymphoma: from chemotherapy to small molecules. Am Soc Clin Oncol Educ Book. 2018, 38:604-15. 10.1200\/EDBK_200829","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30965","article-title":"Diagnosis and management of primary central nervous system lymphoma","volume":"123","author":"Han CH","year":"2017","unstructured":"Han CH, Batchelor TT. Diagnosis and management of primary central nervous system lymphoma. Cancer. 2017, 123:4314-24. 10.1002\/cncr.30965","journal-title":"Cancer"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-017-0920-7","article-title":"Primary central nervous system lymphoma: essential points in diagnosis and management","volume":"34","author":"Paydas S","year":"2017","unstructured":"Paydas S. Primary central nervous system lymphoma: essential points in diagnosis and management. Med Oncol. 2017, 34:61. 10.1007\/s12032-017-0920-7","journal-title":"Med Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2013.606","article-title":"A systematic approach to the diagnosis of suspected central nervous system lymphoma","volume":"70","author":"Scott BJ","year":"2013","unstructured":"Scott BJ, Douglas VC, Tihan T, Rubenstein JL, Josephson SA. A systematic approach to the diagnosis of suspected central nervous system lymphoma. JAMA Neurol. 2013, 70:311-9. 10.1001\/jamaneurol.2013.606","journal-title":"JAMA Neurol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2017.6893","article-title":"Immunohistochemical profile and prognostic significance in primary central nervous system lymphoma: analysis of 89 cases","volume":"14","author":"Liu J","year":"2017","unstructured":"Liu J, Wang Y, Liu Y, et al.. Immunohistochemical profile and prognostic significance in primary central nervous system lymphoma: analysis of 89 cases. Oncol Lett. 2017, 14:5505-12. 10.3892\/ol.2017.6893","journal-title":"Oncol Lett"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.09.139","article-title":"Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience","volume":"21","author":"Ferreri AJ","year":"2003","unstructured":"Ferreri AJ, Blay JY, Reni M, et al.. Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience. J Clin Oncol. 2003, 21:266-72. 10.1200\/JCO.2003.09.139","journal-title":"J Clin Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.46.9957","article-title":"Intensive chemotherapy and immunotherapy in patients with newly diagnosed primary CNS lymphoma: CALGB 50202 (Alliance 50202)","volume":"31","author":"Rubenstein JL","year":"2013","unstructured":"Rubenstein JL, Hsi ED, Johnson JL, et al.. Intensive chemotherapy and immunotherapy in patients with newly diagnosed primary CNS lymphoma: CALGB 50202 (Alliance 50202). J Clin Oncol. 2013, 31:3061-8. 10.1200\/JCO.2012.46.9957","journal-title":"J Clin Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.11771","article-title":"High-dose chemotherapy and autologous stem-cell transplantation without consolidating radiotherapy as first-line treatment for primary lymphoma of the central nervous system","volume":"93","author":"Illerhaus G","year":"2008","unstructured":"Illerhaus G, M\u00fcller F, Feuerhake F, Sch\u00e4fer AO, Ostertag C, Finke J. High-dose chemotherapy and autologous stem-cell transplantation without consolidating radiotherapy as first-line treatment for primary lymphoma of the central nervous system. Haematologica. 2008, 93:147-8. 10.3324\/haematol.11771","journal-title":"Haematologica"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(17)30174-6","article-title":"Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial","volume":"4","author":"Ferreri AJM","year":"2017","unstructured":"Ferreri AJM, Cwynarski K, Pulczynski E, et al.. Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial. Lancet Haematol. 2017, 4:510-23. 10.1016\/S2352-3026(17)30174-6","journal-title":"Lancet Haematol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/426110-a-case-of-primary-central-nervous-system-lymphoma-mimicking-a-demyelinating-disorder-from-steroids-to-stem-cell-transplant","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T09:47:25Z","timestamp":1761040045000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/426110-a-case-of-primary-central-nervous-system-lymphoma-mimicking-a-demyelinating-disorder-from-steroids-to-stem-cell-transplant"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.95037","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,21]]}}}